海外の治験の状況「多発性骨髄腫」での検索結果
170件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Efficacy Study of CYT997 in Multiple Myeloma
- Relapsed and Refractory Multiple Myeloma
- Australia
- 2008-04-18
Not recruiting
- Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
- Relapsed and Refractory Multiple Myeloma
- Australia, Germany, Hong Kong, Italy, Singapore, Spain, United States
- 2014-05-01
Not recruiting
- A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Australia, United States
- 2015-09-25
Not recruiting
- A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
- Multiple Myeloma
- Australia, Canada, Czech Republic, Czechia, France, Germany, Israel, Italy, Netherlands, Russian Federation, Turkey, United Kingdom, United States
- 2014-12-10
Recruiting
- Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
- Relapsed or Refractory Multiple Myeloma
- Australia, Belgium, Canada, Netherlands, Spain, United States
- 2016-10-18
Recruiting
- A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
- Smoldering Multiple Myeloma
- Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom, United States
- 2017-09-29
Not recruiting
- A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Australia, Brazil, Canada, Czechia, France, Greece, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Sweden, Taiwan, Ukraine, United Kingdom, United States
- 2017-09-07
Recruiting
- A Phase 1 Study of AMG 701 in Subjects With Multiple Myeloma
- Relapsed/Refractory Multiple Myeloma
- Australia, Germany, Japan, Netherlands, United States
- 2017-09-06
Recruiting
- Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
- Multiple Myeloma
- Australia, Canada, United States
- 2017-09-05
Recruiting
- MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma
- Relapsed/Refractory Multiple Myeloma
- Australia, Greece, United States
- 2018-03-17